Montse Renom

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

John J. Aponte, Pedro Aíde, Montse Renom et al. · The Lancet · 2007 · 274 citations

Vaccination, Vaccine Safety, Vaccine Development +6

Prevalence and Risk Factors of Sexually Transmitted Infections and Cervical Neoplasia in Women from a Rural Area of Southern Mozambique

Clara Menéndez, Xavier Castellsagué, Montse Renom et al. · Infectious Diseases in Obstetrics and Gynecology · 2010 · 74 citations · Full text

Reproductive Health, Gynecology, Vulvar Diseases +17

Impact of HIV Exposure on Health Outcomes in HIV-Negative Infants Born to HIV-Positive Mothers in Sub-Saharan Africa

Cinta Moraleda, Nilsa de Deus, Celia Serna-Bolea et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 48 citations

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

Pedro Aíde, Carlota Dobaño, Jahit Sacarlal et al. · Vaccine · 2011 · 47 citations

Vaccination, Vaccine Development, Year Immunogenicity +7

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

Pedro Aíde, John J. Aponte, Montse Renom et al. · PLoS ONE · 2010 · 43 citations · Full text